Literature DB >> 31503371

Association of parental substance use disorder with offspring cognition: a population family-based study.

Lotfi Khemiri1, Henrik Larsson2, Ralf Kuja-Halkola2, Brian M D'Onofrio2,3, Paul Lichtenstein2, Nitya Jayaram-Lindström1, Antti Latvala2,4.   

Abstract

AIMS: To assess whether parental substance use disorder (SUD) is associated with lower cognitive ability in offspring, and whether the association is independent of shared genetic factors.
DESIGN: A population family-based cohort study utilizing national Swedish registries. Linear regression with increased adjustment of covariates was performed in the full population. In addition, the mechanism of the association was investigated with children-of-sibling analyses using fixed-effects regression with three types of sibling parents with increasing genetic relatedness (half-siblings, full siblings and monozygotic twins). SETTING AND PARTICIPANTS: A total of 3 004 401 people born in Sweden between 1951 and 1998. MEASUREMENTS: The exposure variable was parental SUD, operationalized as having a parent with life-time SUD diagnosis or substance-related criminal conviction in the National Patient Register or Crime Register, respectively. Outcomes were cognitive test score at military conscription and final school grades when graduating from compulsory school. Covariates included in the analyses were sex, birth year, parental education, parental migration status and parental psychiatric comorbid diagnoses.
FINDINGS: In the full population, parental SUD was associated with decreased cognitive test stanine scores at conscription [4.56, 95% confidence interval (CI) = 4.55-4.57] and lower Z-standardized school grades (-0.43, 95% CI = -0.43 to -0.42) compared to people with no parental SUD (cognitive test: 5.17, 95% CI = 5.17-5.18; grades: 0.09, 95% CI = 0.08-0.09). There was evidence of a dose-response relationship, in that having two parents with SUD (cognitive test: 4.17, 95% CI = 4.15-4.20; grades: -0.83, 95% CI = -0.84 to -0.82) was associated with even lower cognitive ability than having one parent with SUD (cognitive test: 4.60, 95% CI = 4.59-4.60; grades: -0.38, 95% CI = -0.39 to -0.380). In the children-of-siblings analyses when accounting for genetic relatedness, these negative associations were attenuated, suggestive of shared underlying genetic factors.
CONCLUSIONS: There appear to be shared genetic factors between parental substance use disorder (SUD) and offspring cognitive function, suggesting that cognitive deficits may constitute a genetically transmitted risk factor in SUD.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  Addiction; alcohol; cognition; cognitive ability; cognitive dysfunction; parental SUD; school performance; substance use disorder

Year:  2019        PMID: 31503371     DOI: 10.1111/add.14813

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  3 in total

1.  "I Grew Up Amidst Alcohol and Drugs:" a Qualitative Study on the Lived Experiences of Parental Substance Use Among Adults Who Developed Substance Use Disorders Themselves.

Authors:  Florien Meulewaeter; Elisabeth De Schauwer; Sarah S W De Pauw; Wouter Vanderplasschen
Journal:  Front Psychiatry       Date:  2022-02-02       Impact factor: 4.157

2.  Parental Family History of Alcohol Use Disorder and Neural Correlates of Response Inhibition in Children From the Adolescent Brain Cognitive Development (ABCD) Study.

Authors:  Briana Lees; Laika Aguinaldo; Lindsay M Squeglia; Maria Alejandra Infante; Natasha E Wade; Margie Hernandez Mejia; Joanna Jacobus
Journal:  Alcohol Clin Exp Res       Date:  2020-05-18       Impact factor: 3.455

3.  Systematic Review and Meta-analysis of Genetically Informed Research: Associations Between Parent Anxiety and Offspring Internalizing Problems.

Authors:  Yasmin I Ahmadzadeh; Tabea Schoeler; Meredith Han; Jean-Baptiste Pingault; Cathy Creswell; Tom A McAdams
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-03-03       Impact factor: 8.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.